Description of deaths from cervical cancer in the population of Recife-PE, from 2019 to 2021

Abstract

Cancer of the Uterus (UCC) is a disease that affects thousands of women worldwide, where, present the factor for the pathology, the presence of HPV viruses 16 and 18. The screening of UCC in Brazil is performed through the cytological exam, however, along with this and examination there are barriers that need to be overcome. It is identified that this neoplasm has a high incidence and prevalence in the Brazilian female population, especially in the State of Pernambuco in its capital Recife. Thence, in the State every day occurs a death as a result of UCC. So, to occur an organized screening of the and accurate to get diagnosis of where the women in the age group are for screening, focus on women of higher risk age group and who do not do the pathological cite examination. To verify the data for organized UCC screening, number of women in eligible age group, locality of residence and cytological coverage in the population of Recife-PE. This is an epidemiological cohort study with a cross-sectional, descriptive approach , with a quantitative approach, whose data were collected through the secondary database of the Primary Care Information System (SISAB/SUS), E-SUS AB, provided by DATASUS/Ministry of Health. The population consisted of women registered in the E-SUS AB, registered in the Health Units of the Health Districts (SD) in the city of Recife-PE, in the temporal cohort from the years 2019 to 2021. The results showed that in a total population of 481,453 women, 164,650 women underwent the preventive examination. That is not even 34% of the population. Deaths from UCC is predominant among the 40-49 years, with 26% of the population, between the years 2019-2021. Confirming 67 deaths in 2021, with predominance in the II, IV and VII District. That with the high number of incidence and deaths from UCC, the present study can raise awareness of women for the participation of screening, whether by the "Papanicolau" or by HPV-DNA, and thus contribute to the reduction of the incidence and deaths from UCC.